Infection poses one of the most serious risks to patients getting a hip or knee replaced, and a major U.S. drugmaker is developing a test to quickly identify the pathogens responsible so doctors can treat problems sooner.
Abbott Diagnostics Group, a unit of Abbott Laboratories, is working with privately held Genetics Laboratory Inc., whose expertise is in orthopedics, to develop the test.
It will be based on Abbott's PLEX-ID system for identifying microbes, and is expected to help doctors detect infections that become rooted in the body's joints long before they become apparent through physical symptoms. NewsMax Health
No comments:
Post a Comment